Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages

Nature Immunology

Volumn 12, Issue 7, 2011, Pages 607-615

  Park, Sung Ho ^a,b   Park Min, Kyung Hyun ^b   Chen, Janice ^b   Hu, Xiaoyu ^b   Ivashkiv, Lionel B ^a,b  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GLYCOGEN SYNTHASE KINASE 3; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROTECTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; CROSS TOLERANCE; CYTOKINE PRODUCTION; EPIGENETICS; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION;

ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYSTEINE ENDOPEPTIDASES; CYTOKINES; ENDOTOXINS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; I-KAPPA B PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959373435     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2043     Document Type: Article

References (49)

1. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
2. Beutler, B. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol. Rev. 227, 248-263 (2009).
3. Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.A.J. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458 (2005). (Pubitemid 40835033)
4. Biswas, S.K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475-487 (2009).
5. Foster, S.L., Hargreaves, D.C. & Medzhitov, R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972-978 (2007). (Pubitemid 46975746)
6. Foster, S.L. & Medzhitov, R. Gene-specific control of the TLR-induced inflammatory response. Clin. Immunol. 130, 7-15 (2009).
7. Smale, S.T. Selective transcription in response to an inflammatory stimulus. Cell 140, 833-844 (2010).
8. Nathan, C. & Ding, A. Nonresolving inflammation. Cell 140, 871-882 (2010).
9. Hodge-Dufour, J. et al. Inhibition of interferon γ induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 95, 13806-13811 (1998). (Pubitemid 28523054)
10. Williams-Skipp, C. et al. Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model. Arthritis Rheum. 60, 408-418 (2009).
11. Blüml, S. et al. Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis. Arthritis Rheum. 62, 1608-1619 (2010).
12. Zakharova, M. & Ziegler, H.K. Paradoxical anti-inflammatory actions of TNF-α: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells. J. Immunol. 175, 5024-5033 (2005). (Pubitemid 41456385)
13. Marino, M.W. et al. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94, 8093-8098 (1997). (Pubitemid 27343782)
14. Kollias, G., Douni, E., Kassiotis, G. & Kontoyiannis, D. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 169, 175-194 (1999). (Pubitemid 29338732)
15. Banchereau, J. & Pascual, V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25, 383-392 (2006). (Pubitemid 44354221)
16. Doble, B.W. & Woodgett, J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186 (2003). (Pubitemid 36410657)
17. Martin, M., Rehani, K., Jope, R.S. & Michalek, S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777-784 (2005). (Pubitemid 43090463)
18. Hu, X. et al. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24, 563-574 (2006). (Pubitemid 43728157)
19. Beurel, E., Michalek, S.M. & Jope, R.S. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 31, 24-31 (2010).
20. Steinbrecher, K.A., Wilson, W., Cogswell, P.C. & Baldwin, A.S. Glycogen synthase kinase 3β functions to specify gene-specific, NF-κB-dependent transcription. Mol. Cell. Biol. 25, 8444-8455 (2005). (Pubitemid 41369166)
21. Buss, H. et al. Phosphorylation of serine 468 by GSK-3β negatively regulates basal p65 NF-κB activity. J. Biol. Chem. 279, 49571-49574 (2004). (Pubitemid 39577758)
22. Saijo, K. et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47-59 (2009).
23. Takada, Y. et al. Genetic deletion of glycogen synthase kinase-3β abrogates activation of IκBα kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J. Biol. Chem. 279, 39541-39554 (2004). (Pubitemid 39258221)
24. Hoeflich, K.P. et al. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406, 86-90 (2000). (Pubitemid 30460216)
25. Rodionova, E. et al. GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood 109, 1584-1592 (2007). (Pubitemid 46239592)
26. Shen, F. et al. IL-17 receptor signaling inhibits C/EBPβ by sequential phosphorylation of the regulatory 2 domain. Sci. Signal. 2, ra8 (2009).
27. Shen, E., Fan, J. & Peng, T. Glycogen synthase kinase-3β suppresses tumor necrosis factor-α expression in cardiomyocytes during lipopolysaccharide stimulation. J. Cell. Biochem. 104, 329-338 (2008).
28. Vines, A. et al. Novel anti-inflammatory role for glycogen synthase kinase-3β in the inhibition of tumor necrosis factor-α- and interleukin-1β-induced inflammatory gene expression. J. Biol. Chem. 281, 16985-16990 (2006).
29. Jafferany, M. Lithium and skin: dermatologic manifestations of lithium therapy. Int. J. Dermatol. 47, 1101-1111 (2008).
30. del Fresno, C. et al. Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes. J. Endotoxin Res. 13, 39-52 (2007).
31. Kawasaki, T. et al. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth. Analg. 92, 1322-1326 (2001). (Pubitemid 32385966)
32. Langdale, L.A., Kajikawa, O., Frevert, C. & Liggitt, H.D. Sustained tolerance to lipopolysaccharide after liver ischemia-reperfusion injury. Shock 19, 553-558 (2003).
33. Chen, J. & Ivashkiv, L.B. IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc. Natl. Acad. Sci. USA 107, 19438-19443 (2010).
34. Hayden, M.S. & Ghosh, S. Shared principles in NF-κB signaling. Cell 132, 344-362 (2008).
35. Boone, D.L. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052-1060 (2004). (Pubitemid 41057725)
36. Patel, S. et al. Tissue-specific role of glycogen synthase kinase 3β in glucose homeostasis and insulin action. Mol. Cell. Biol. 28, 6314-6328 (2008).
37. Werner, S.L. et al. Encoding NF-κB temporal control in response to TNF: distinct roles for the negative regulators IκBα and A20. Genes Dev. 22, 2093-2101 (2008).
38. Saccani, S., Pantano, S. & Natoli, G. p38-Dependent marking of inflammatory genes for increased NF-κB recruitment. Nat. Immunol. 3, 69-75 (2002). (Pubitemid 34065620)
39. Weinmann, A.S. et al. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat. Immunol. 2, 51-57 (2001). (Pubitemid 33704953)
40. Ramirez-Carrozzi, V.R. et al. Selective and antagonistic functions of SWI/SNF and Mi-2β nucleosome remodeling complexes during an inflammatory response. Genes Dev. 20, 282-296 (2006). (Pubitemid 43200283)
41. Aggarwal, B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745-756 (2003). (Pubitemid 41070815)
42. Christen, U. et al. A dual role for TNF-α in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 166, 7023-7032 (2001). (Pubitemid 32525571)
43. Hassett, S., Moynagh, P. & Reen, D. TNF-α is a mediator of the anti-inflammatory response in a human neonatal model of the non-septic shock syndrome. Pediatr. Surg. Int. 22, 24-30 (2006). (Pubitemid 43052195)
44. Kassiotis, G. & Kollias, G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 193, 427-434 (2001). (Pubitemid 32524474)
45. Stahl, E.A. et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42, 508-514 (2010).
46. Plenge, R.M. et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 39, 1477-1482 (2007). (Pubitemid 350191346)
47. Natoli, G., Saccani, S., Bosisio, D. & Marazzi, I. Interactions of NF-κB with chromatin: the art of being at the right place at the right time. Nat. Immunol. 6, 439-445 (2005). (Pubitemid 41716756)
48. Werner, S.L., Barken, D. & Hoffmann, A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309, 1857-1861 (2005). (Pubitemid 41325096)
49. Yarilina, A. et al. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat. Immunol. 9, 378-387 (2008). (Pubitemid 351405107)